General Partner, Inc. Novo Nordisk A S Transaction History
General Partner, Inc.
- $154 Billion
- Q1 2025
A detailed history of General Partner, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, General Partner, Inc. holds 2,080 shares of NVO stock, worth $146,515. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,080
Previous 880
136.36%
Holding current value
$146,515
Previous $75.7 Million
90.8%
% of portfolio
0.09%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.33 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.04 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$873 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$868 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$836 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $159B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...